Provided by Tiger Trade Technology Pte. Ltd.

Viatris Inc.

17.64
+0.20001.15%
Post-market: 17.850.2100+1.19%19:43 EDT
Volume:8.83M
Turnover:154.98M
Market Cap:20.27B
PE:-49.78
High:17.76
Open:17.36
Low:17.19
Close:17.44
52wk High:18.43
52wk Low:9.69
Shares:1.15B
Float Shares:1.14B
Volume Ratio:1.05
T/O Rate:0.77%
Dividend:0.48
Dividend Rate:2.72%
EPS(TTM):-0.3543
EPS(LYR):-3.0024
ROE:-2.75%
ROA:2.67%
PB:1.42
PE(LYR):-5.88

Loading ...

Viatris Inc. Stock Rises Friday, Outperforms Market

Dow Jones
·
7 hours ago

Pacira Biosciences' Acquisition by Viatris Unlikely to See Superior Bid, RBC Says

MT Newswires Live
·
Yesterday

Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Tilray (TLRY) and Viatris (VTRS)

TIPRANKS
·
Yesterday

Deals of the Day-Mergers and Acquisitions

Reuters
·
Yesterday

Top Midday Gainers

MT Newswires Live
·
Yesterday

US Stocks on the MOVE-Palantir, Haemonetics

Reuters
·
Yesterday

Why Pacira BioSciences Stock is Having Its Best Day Ever After $1.7 Billion Viatris Acquisition

Dow Jones
·
Yesterday

Pacira downgraded to Perform from Outperform at Oppenheimer

TIPRANKS
·
Yesterday

Sector Update: Healthcare

MT Newswires Live
·
Yesterday

Top Midday Stories: Microsoft, Adobe Among Tech Firms Suspended From US Immigration Program; Starbucks Has Explored Chipotle Takeover

MT Newswires Live
·
Oct 08

Pacira downgraded to Hold from Buy at Needham

TIPRANKS
·
Oct 08

Viatris to Buy Pain Therapy Maker Pacira BioSciences for $1.65 Billion

Reuters
·
Oct 08

Viatris - Pacira to Pay Viatris $62 Million Termination Fee Under Specified Circumstances

Reuters
·
Oct 08

Viatris - Pacira to Pay Viatris $62 Mln Termination Fee Under Specified Circumstances - SEC Filing

THOMSON REUTERS
·
Oct 08

Incorrect Alert on Pacira Biosciences' Share Movement Withdrawn

Reuters
·
Oct 08

Pacira Biosciences Shares up 2% Premarket After Viatris to Acquire Co in $1.65 Bln Deal

THOMSON REUTERS
·
Oct 08

Viatris Agrees to Buy Pacira BioSciences for $36.50 a Share in Cash, Valuing Deal at $1.65 Billion

Reuters
·
Oct 08

Viatris - Deal Expected to Close by End of 2026 and be Immediately Accretive

THOMSON REUTERS
·
Oct 08

Viatris - to Buy Pacira for $36.5 Per Share, Equity Value $1.65 Bln

THOMSON REUTERS
·
Oct 08

Viatris Agrees to Acquire Pacira Biosciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies

THOMSON REUTERS
·
Oct 08